chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Blood iron, Bundle branch block left, C-reactive protein increased, COVID-19, Chest X-ray normal
Clinical narrative: Patient is a 93 y.o. female patient of local MD with history of CAD, HTN and AS who presented to Hospital with a cc of progressive DOE      Acute pulmonary embolism with RHS  COVID 19 infection  P/w acute onset DOE.  Etiology likely multifactorial given findings below   CXR: relatively unremarkable  CTPA with RLL PE w/ RHS, e/o Pulm HTN  Echo outlined below   LE duplex negative for DVT  Started on heparin, transitioned to warfarin with lovenox bridge.    CRP elevated, will monitor while in house.  Decadron and remdesivir per COVID 19 protocol with plans to discharge on decadron for 10 total days of therapy   Stable on RA at time of discharge    Acute macrocytic anemia  Baseline hgb 12-13, dropped to 10.7 today in the setting of anticoagulation  Macrocytosis concerning for acute bleed however no melena, hematochezia or hematemesis   iron studies, B12 level reviewed.  Continue PO iron on discharge  Repeat CBC in 1 week in outpatient setting    New onset systolic heart failure  Severe tricuspid regurgitation  Severe aortic stenosis   Pulmonary HTN   NSTEMI, unable to determine type as refused ischemic w/u  Echo obtained in the setting of PE and e/o RHS on CTPA  Echo: LVEF 39% (down from 60%), severe AS, severe TR and multiple WMA noted. RVSP 80mmhg   EKG w/ LBBB which is chronic   Evaluated by cardiology, patient has declined any ischemic w/u at this time and has opted for medical management   Continue statin, BB and ACEi as well as plavix on discharge  RX for PRN lasix on discharge given EF and valve disease    Cancer screening  No recent mammogram.  Last colonoscopy 2016.    Will defer cancer screening to the outpatient setting though unlikely to change management    Urinary frequency  Noted today, UA pending collection  Will f/u UA and send RX for abx if indicated.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea exertional, Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram abnormal
Clinical narrative: Patient is a 93 y.o. female patient of local MD with history of CAD, HTN and AS who presented to Hospital with a cc of progressive DOE      Acute pulmonary embolism with RHS  COVID 19 infection  P/w acute onset DOE.  Etiology likely multifactorial given findings below   CXR: relatively unremarkable  CTPA with RLL PE w/ RHS, e/o Pulm HTN  Echo outlined below   LE duplex negative for DVT  Started on heparin, transitioned to warfarin with lovenox bridge.    CRP elevated, will monitor while in house.  Decadron and remdesivir per COVID 19 protocol with plans to discharge on decadron for 10 total days of therapy   Stable on RA at time of discharge    Acute macrocytic anemia  Baseline hgb 12-13, dropped to 10.7 today in the setting of anticoagulation  Macrocytosis concerning for acute bleed however no melena, hematochezia or hematemesis   iron studies, B12 level reviewed.  Continue PO iron on discharge  Repeat CBC in 1 week in outpatient setting    New onset systolic heart failure  Severe tricuspid regurgitation  Severe aortic stenosis   Pulmonary HTN   NSTEMI, unable to determine type as refused ischemic w/u  Echo obtained in the setting of PE and e/o RHS on CTPA  Echo: LVEF 39% (down from 60%), severe AS, severe TR and multiple WMA noted. RVSP 80mmhg   EKG w/ LBBB which is chronic   Evaluated by cardiology, patient has declined any ischemic w/u at this time and has opted for medical management   Continue statin, BB and ACEi as well as plavix on discharge  RX for PRN lasix on discharge given EF and valve disease    Cancer screening  No recent mammogram.  Last colonoscopy 2016.    Will defer cancer screening to the outpatient setting though unlikely to change management    Urinary frequency  Noted today, UA pending collection  Will f/u UA and send RX for abx if indicated.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Left ventricular failure, Pollakiuria, Pulmonary embolism, Pulmonary hypertension
Clinical narrative: Patient is a 93 y.o. female patient of local MD with history of CAD, HTN and AS who presented to Hospital with a cc of progressive DOE      Acute pulmonary embolism with RHS  COVID 19 infection  P/w acute onset DOE.  Etiology likely multifactorial given findings below   CXR: relatively unremarkable  CTPA with RLL PE w/ RHS, e/o Pulm HTN  Echo outlined below   LE duplex negative for DVT  Started on heparin, transitioned to warfarin with lovenox bridge.    CRP elevated, will monitor while in house.  Decadron and remdesivir per COVID 19 protocol with plans to discharge on decadron for 10 total days of therapy   Stable on RA at time of discharge    Acute macrocytic anemia  Baseline hgb 12-13, dropped to 10.7 today in the setting of anticoagulation  Macrocytosis concerning for acute bleed however no melena, hematochezia or hematemesis   iron studies, B12 level reviewed.  Continue PO iron on discharge  Repeat CBC in 1 week in outpatient setting    New onset systolic heart failure  Severe tricuspid regurgitation  Severe aortic stenosis   Pulmonary HTN   NSTEMI, unable to determine type as refused ischemic w/u  Echo obtained in the setting of PE and e/o RHS on CTPA  Echo: LVEF 39% (down from 60%), severe AS, severe TR and multiple WMA noted. RVSP 80mmhg   EKG w/ LBBB which is chronic   Evaluated by cardiology, patient has declined any ischemic w/u at this time and has opted for medical management   Continue statin, BB and ACEi as well as plavix on discharge  RX for PRN lasix on discharge given EF and valve disease    Cancer screening  No recent mammogram.  Last colonoscopy 2016.    Will defer cancer screening to the outpatient setting though unlikely to change management    Urinary frequency  Noted today, UA pending collection  Will f/u UA and send RX for abx if indicated.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Tricuspid valve incompetence, Ultrasound Doppler normal, Vitamin B12
Clinical narrative: Patient is a 93 y.o. female patient of local MD with history of CAD, HTN and AS who presented to Hospital with a cc of progressive DOE      Acute pulmonary embolism with RHS  COVID 19 infection  P/w acute onset DOE.  Etiology likely multifactorial given findings below   CXR: relatively unremarkable  CTPA with RLL PE w/ RHS, e/o Pulm HTN  Echo outlined below   LE duplex negative for DVT  Started on heparin, transitioned to warfarin with lovenox bridge.    CRP elevated, will monitor while in house.  Decadron and remdesivir per COVID 19 protocol with plans to discharge on decadron for 10 total days of therapy   Stable on RA at time of discharge    Acute macrocytic anemia  Baseline hgb 12-13, dropped to 10.7 today in the setting of anticoagulation  Macrocytosis concerning for acute bleed however no melena, hematochezia or hematemesis   iron studies, B12 level reviewed.  Continue PO iron on discharge  Repeat CBC in 1 week in outpatient setting    New onset systolic heart failure  Severe tricuspid regurgitation  Severe aortic stenosis   Pulmonary HTN   NSTEMI, unable to determine type as refused ischemic w/u  Echo obtained in the setting of PE and e/o RHS on CTPA  Echo: LVEF 39% (down from 60%), severe AS, severe TR and multiple WMA noted. RVSP 80mmhg   EKG w/ LBBB which is chronic   Evaluated by cardiology, patient has declined any ischemic w/u at this time and has opted for medical management   Continue statin, BB and ACEi as well as plavix on discharge  RX for PRN lasix on discharge given EF and valve disease    Cancer screening  No recent mammogram.  Last colonoscopy 2016.    Will defer cancer screening to the outpatient setting though unlikely to change management    Urinary frequency  Noted today, UA pending collection  Will f/u UA and send RX for abx if indicated.
Age: 5.0
Sex: F
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration, Pyrexia
Clinical narrative: Pt received a COVID booster 1 week after getting a booster. She has a fever of 103
Age: 41.0
Sex: M
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: Patient came in with his family of 4 people. All of them signed up for a covid booster and flu shot, except for him. There was a language barrier and we did not realize that he didn't want to receive the updated covid booster. He received the booster and did not request the vaccine
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory distress syndrome, Agitation, Angiogram pulmonary, Anticoagulant therapy, Asthenia
Clinical narrative: Discharge Diagnoses and Hospital Course:   Patient is a 74 y.o. female who presented to local General Hospital 10/21/2022 with urinary tract infection and chest pain.    1. UTI, E. Coli (resolved) - Completed regimen of IV zosyn.   2. Right Sacral Ala and Superior/Inferior Rami Fractures             -Since the prior MRI of the left hip of 06/18/2022 there has been development of acute/subacute nondisplaced insufficiency fractures involving the right sacral ala and the right superior and inferior pubic rami. Dr. saw patient inpatient and signed off. Non-surgical. WBTT with PT             - Continue with pain management.   3. Generalized Weakness             - PT/OT were consulted    4. Chest Pain             -Stress test: Patient with a recent stress test on 10/26/2022 that was negative for any ischemia.  Overall low risk study.   5. Morbid Obesity with BMI 36               6. History of paroxysmal atrial fibrillation             -Anticoagulation contraindicated secondary to GI bleed   7. Hypertension   8. COPD   9. Cognitive Dysfunction             -Continue with redirection/orientation.   10.  Chronic CHFpEF             -Improved with IV Lasix.   11. Hypokalemia             -Secondary to IV diuresis.  Potassium supplementation was given.   12. COVID 19, ARDS .Covid-19 Virus Infection Date of onset of symptoms:  Saturday 10/29/22 per patient  Symptoms present on admission: Hypoxemia/ cough/ rhinorrhea/ nasal congestion Date of covid positive test:  10/31/22 Vaccination status:  vaccinated per chart. Imaging:   CXR on 10/30, CTPA 11/6 completed  Oxygen requirements on admission:  2L baseline Current oxygen requirements: Bipap Medical therapy: decadron ARDS dosing (20mg x5 days, then 10mg x5 , Day #2/5 for 20mg)/remdesivir day 2 of 5 Consultants following:  Pulmonology/palliative. Anticipated special isolation end date: 11/19/22 Transitioning to inpatient hospice today - stopping steroids and remdesivir per d/w family re: GOC    13.Other chronic stable medical conditions: History of CVA in June 2022, anxiety, depression, peripheral neuropathy, chronic anemia    14. COVID delirium             - will defer to palliative team to help with agitation.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, COVID-19, Cardiac failure, Cardiac stress test normal, Cerebrovascular accident
Clinical narrative: Discharge Diagnoses and Hospital Course:   Patient is a 74 y.o. female who presented to local General Hospital 10/21/2022 with urinary tract infection and chest pain.    1. UTI, E. Coli (resolved) - Completed regimen of IV zosyn.   2. Right Sacral Ala and Superior/Inferior Rami Fractures             -Since the prior MRI of the left hip of 06/18/2022 there has been development of acute/subacute nondisplaced insufficiency fractures involving the right sacral ala and the right superior and inferior pubic rami. Dr. saw patient inpatient and signed off. Non-surgical. WBTT with PT             - Continue with pain management.   3. Generalized Weakness             - PT/OT were consulted    4. Chest Pain             -Stress test: Patient with a recent stress test on 10/26/2022 that was negative for any ischemia.  Overall low risk study.   5. Morbid Obesity with BMI 36               6. History of paroxysmal atrial fibrillation             -Anticoagulation contraindicated secondary to GI bleed   7. Hypertension   8. COPD   9. Cognitive Dysfunction             -Continue with redirection/orientation.   10.  Chronic CHFpEF             -Improved with IV Lasix.   11. Hypokalemia             -Secondary to IV diuresis.  Potassium supplementation was given.   12. COVID 19, ARDS .Covid-19 Virus Infection Date of onset of symptoms:  Saturday 10/29/22 per patient  Symptoms present on admission: Hypoxemia/ cough/ rhinorrhea/ nasal congestion Date of covid positive test:  10/31/22 Vaccination status:  vaccinated per chart. Imaging:   CXR on 10/30, CTPA 11/6 completed  Oxygen requirements on admission:  2L baseline Current oxygen requirements: Bipap Medical therapy: decadron ARDS dosing (20mg x5 days, then 10mg x5 , Day #2/5 for 20mg)/remdesivir day 2 of 5 Consultants following:  Pulmonology/palliative. Anticipated special isolation end date: 11/19/22 Transitioning to inpatient hospice today - stopping steroids and remdesivir per d/w family re: GOC    13.Other chronic stable medical conditions: History of CVA in June 2022, anxiety, depression, peripheral neuropathy, chronic anemia    14. COVID delirium             - will defer to palliative team to help with agitation.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Chest pain, Chronic obstructive pulmonary disease, Cognitive disorder, Cough
Clinical narrative: Discharge Diagnoses and Hospital Course:   Patient is a 74 y.o. female who presented to local General Hospital 10/21/2022 with urinary tract infection and chest pain.    1. UTI, E. Coli (resolved) - Completed regimen of IV zosyn.   2. Right Sacral Ala and Superior/Inferior Rami Fractures             -Since the prior MRI of the left hip of 06/18/2022 there has been development of acute/subacute nondisplaced insufficiency fractures involving the right sacral ala and the right superior and inferior pubic rami. Dr. saw patient inpatient and signed off. Non-surgical. WBTT with PT             - Continue with pain management.   3. Generalized Weakness             - PT/OT were consulted    4. Chest Pain             -Stress test: Patient with a recent stress test on 10/26/2022 that was negative for any ischemia.  Overall low risk study.   5. Morbid Obesity with BMI 36               6. History of paroxysmal atrial fibrillation             -Anticoagulation contraindicated secondary to GI bleed   7. Hypertension   8. COPD   9. Cognitive Dysfunction             -Continue with redirection/orientation.   10.  Chronic CHFpEF             -Improved with IV Lasix.   11. Hypokalemia             -Secondary to IV diuresis.  Potassium supplementation was given.   12. COVID 19, ARDS .Covid-19 Virus Infection Date of onset of symptoms:  Saturday 10/29/22 per patient  Symptoms present on admission: Hypoxemia/ cough/ rhinorrhea/ nasal congestion Date of covid positive test:  10/31/22 Vaccination status:  vaccinated per chart. Imaging:   CXR on 10/30, CTPA 11/6 completed  Oxygen requirements on admission:  2L baseline Current oxygen requirements: Bipap Medical therapy: decadron ARDS dosing (20mg x5 days, then 10mg x5 , Day #2/5 for 20mg)/remdesivir day 2 of 5 Consultants following:  Pulmonology/palliative. Anticipated special isolation end date: 11/19/22 Transitioning to inpatient hospice today - stopping steroids and remdesivir per d/w family re: GOC    13.Other chronic stable medical conditions: History of CVA in June 2022, anxiety, depression, peripheral neuropathy, chronic anemia    14. COVID delirium             - will defer to palliative team to help with agitation.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Delirium, Diuretic therapy, Escherichia urinary tract infection, Fractured sacrum, Gastrointestinal haemorrhage
Clinical narrative: Discharge Diagnoses and Hospital Course:   Patient is a 74 y.o. female who presented to local General Hospital 10/21/2022 with urinary tract infection and chest pain.    1. UTI, E. Coli (resolved) - Completed regimen of IV zosyn.   2. Right Sacral Ala and Superior/Inferior Rami Fractures             -Since the prior MRI of the left hip of 06/18/2022 there has been development of acute/subacute nondisplaced insufficiency fractures involving the right sacral ala and the right superior and inferior pubic rami. Dr. saw patient inpatient and signed off. Non-surgical. WBTT with PT             - Continue with pain management.   3. Generalized Weakness             - PT/OT were consulted    4. Chest Pain             -Stress test: Patient with a recent stress test on 10/26/2022 that was negative for any ischemia.  Overall low risk study.   5. Morbid Obesity with BMI 36               6. History of paroxysmal atrial fibrillation             -Anticoagulation contraindicated secondary to GI bleed   7. Hypertension   8. COPD   9. Cognitive Dysfunction             -Continue with redirection/orientation.   10.  Chronic CHFpEF             -Improved with IV Lasix.   11. Hypokalemia             -Secondary to IV diuresis.  Potassium supplementation was given.   12. COVID 19, ARDS .Covid-19 Virus Infection Date of onset of symptoms:  Saturday 10/29/22 per patient  Symptoms present on admission: Hypoxemia/ cough/ rhinorrhea/ nasal congestion Date of covid positive test:  10/31/22 Vaccination status:  vaccinated per chart. Imaging:   CXR on 10/30, CTPA 11/6 completed  Oxygen requirements on admission:  2L baseline Current oxygen requirements: Bipap Medical therapy: decadron ARDS dosing (20mg x5 days, then 10mg x5 , Day #2/5 for 20mg)/remdesivir day 2 of 5 Consultants following:  Pulmonology/palliative. Anticipated special isolation end date: 11/19/22 Transitioning to inpatient hospice today - stopping steroids and remdesivir per d/w family re: GOC    13.Other chronic stable medical conditions: History of CVA in June 2022, anxiety, depression, peripheral neuropathy, chronic anemia    14. COVID delirium             - will defer to palliative team to help with agitation.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Hypokalaemia, Hypoxia, Magnetic resonance imaging abnormal, Malaise
Clinical narrative: Discharge Diagnoses and Hospital Course:   Patient is a 74 y.o. female who presented to local General Hospital 10/21/2022 with urinary tract infection and chest pain.    1. UTI, E. Coli (resolved) - Completed regimen of IV zosyn.   2. Right Sacral Ala and Superior/Inferior Rami Fractures             -Since the prior MRI of the left hip of 06/18/2022 there has been development of acute/subacute nondisplaced insufficiency fractures involving the right sacral ala and the right superior and inferior pubic rami. Dr. saw patient inpatient and signed off. Non-surgical. WBTT with PT             - Continue with pain management.   3. Generalized Weakness             - PT/OT were consulted    4. Chest Pain             -Stress test: Patient with a recent stress test on 10/26/2022 that was negative for any ischemia.  Overall low risk study.   5. Morbid Obesity with BMI 36               6. History of paroxysmal atrial fibrillation             -Anticoagulation contraindicated secondary to GI bleed   7. Hypertension   8. COPD   9. Cognitive Dysfunction             -Continue with redirection/orientation.   10.  Chronic CHFpEF             -Improved with IV Lasix.   11. Hypokalemia             -Secondary to IV diuresis.  Potassium supplementation was given.   12. COVID 19, ARDS .Covid-19 Virus Infection Date of onset of symptoms:  Saturday 10/29/22 per patient  Symptoms present on admission: Hypoxemia/ cough/ rhinorrhea/ nasal congestion Date of covid positive test:  10/31/22 Vaccination status:  vaccinated per chart. Imaging:   CXR on 10/30, CTPA 11/6 completed  Oxygen requirements on admission:  2L baseline Current oxygen requirements: Bipap Medical therapy: decadron ARDS dosing (20mg x5 days, then 10mg x5 , Day #2/5 for 20mg)/remdesivir day 2 of 5 Consultants following:  Pulmonology/palliative. Anticipated special isolation end date: 11/19/22 Transitioning to inpatient hospice today - stopping steroids and remdesivir per d/w family re: GOC    13.Other chronic stable medical conditions: History of CVA in June 2022, anxiety, depression, peripheral neuropathy, chronic anemia    14. COVID delirium             - will defer to palliative team to help with agitation.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Mineral supplementation, Nasal congestion, Obesity, Pelvic fracture, Positive airway pressure therapy
Clinical narrative: Discharge Diagnoses and Hospital Course:   Patient is a 74 y.o. female who presented to local General Hospital 10/21/2022 with urinary tract infection and chest pain.    1. UTI, E. Coli (resolved) - Completed regimen of IV zosyn.   2. Right Sacral Ala and Superior/Inferior Rami Fractures             -Since the prior MRI of the left hip of 06/18/2022 there has been development of acute/subacute nondisplaced insufficiency fractures involving the right sacral ala and the right superior and inferior pubic rami. Dr. saw patient inpatient and signed off. Non-surgical. WBTT with PT             - Continue with pain management.   3. Generalized Weakness             - PT/OT were consulted    4. Chest Pain             -Stress test: Patient with a recent stress test on 10/26/2022 that was negative for any ischemia.  Overall low risk study.   5. Morbid Obesity with BMI 36               6. History of paroxysmal atrial fibrillation             -Anticoagulation contraindicated secondary to GI bleed   7. Hypertension   8. COPD   9. Cognitive Dysfunction             -Continue with redirection/orientation.   10.  Chronic CHFpEF             -Improved with IV Lasix.   11. Hypokalemia             -Secondary to IV diuresis.  Potassium supplementation was given.   12. COVID 19, ARDS .Covid-19 Virus Infection Date of onset of symptoms:  Saturday 10/29/22 per patient  Symptoms present on admission: Hypoxemia/ cough/ rhinorrhea/ nasal congestion Date of covid positive test:  10/31/22 Vaccination status:  vaccinated per chart. Imaging:   CXR on 10/30, CTPA 11/6 completed  Oxygen requirements on admission:  2L baseline Current oxygen requirements: Bipap Medical therapy: decadron ARDS dosing (20mg x5 days, then 10mg x5 , Day #2/5 for 20mg)/remdesivir day 2 of 5 Consultants following:  Pulmonology/palliative. Anticipated special isolation end date: 11/19/22 Transitioning to inpatient hospice today - stopping steroids and remdesivir per d/w family re: GOC    13.Other chronic stable medical conditions: History of CVA in June 2022, anxiety, depression, peripheral neuropathy, chronic anemia    14. COVID delirium             - will defer to palliative team to help with agitation.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Therapy cessation
Clinical narrative: Discharge Diagnoses and Hospital Course:   Patient is a 74 y.o. female who presented to local General Hospital 10/21/2022 with urinary tract infection and chest pain.    1. UTI, E. Coli (resolved) - Completed regimen of IV zosyn.   2. Right Sacral Ala and Superior/Inferior Rami Fractures             -Since the prior MRI of the left hip of 06/18/2022 there has been development of acute/subacute nondisplaced insufficiency fractures involving the right sacral ala and the right superior and inferior pubic rami. Dr. saw patient inpatient and signed off. Non-surgical. WBTT with PT             - Continue with pain management.   3. Generalized Weakness             - PT/OT were consulted    4. Chest Pain             -Stress test: Patient with a recent stress test on 10/26/2022 that was negative for any ischemia.  Overall low risk study.   5. Morbid Obesity with BMI 36               6. History of paroxysmal atrial fibrillation             -Anticoagulation contraindicated secondary to GI bleed   7. Hypertension   8. COPD   9. Cognitive Dysfunction             -Continue with redirection/orientation.   10.  Chronic CHFpEF             -Improved with IV Lasix.   11. Hypokalemia             -Secondary to IV diuresis.  Potassium supplementation was given.   12. COVID 19, ARDS .Covid-19 Virus Infection Date of onset of symptoms:  Saturday 10/29/22 per patient  Symptoms present on admission: Hypoxemia/ cough/ rhinorrhea/ nasal congestion Date of covid positive test:  10/31/22 Vaccination status:  vaccinated per chart. Imaging:   CXR on 10/30, CTPA 11/6 completed  Oxygen requirements on admission:  2L baseline Current oxygen requirements: Bipap Medical therapy: decadron ARDS dosing (20mg x5 days, then 10mg x5 , Day #2/5 for 20mg)/remdesivir day 2 of 5 Consultants following:  Pulmonology/palliative. Anticipated special isolation end date: 11/19/22 Transitioning to inpatient hospice today - stopping steroids and remdesivir per d/w family re: GOC    13.Other chronic stable medical conditions: History of CVA in June 2022, anxiety, depression, peripheral neuropathy, chronic anemia    14. COVID delirium             - will defer to palliative team to help with agitation.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, C-reactive protein increased, COVID-19, Cardiac failure, Chest X-ray abnormal
Clinical narrative: Patient is a 68 y.o. female patient of MD with history of  of Anxiety, CHF, Atrial tachycardia, COPD with chronic respiratory failure, seizures OSA presented to the local Hospital with SOB, +COVID infection   Acute on Chronic hypoxic respiratory failure COVID19 infection -patient vaccinated but did not receive booster COPD/OSA + symptoms started more than one week ago with non productive cough and increase SOB CXR stable with chronic mild hazy density throughout both lungs On 2 lit NC 02 and trilogy at home at baseline Required up to 3 L but now down to her baseline of 2 L O2 requirement  elevated CRP, improvement noted with Decadron. Decadron, Mucinex, IS/PEP upon discharge Continued breathing treatment and homeTrilogy   HFpEF, chronic ECHO in 2020 EF 65 %. grade I diastolic dysfunction, consistent with low or normal atrial pressures. RVSP 25 mmHg. Low suspicion for exacerbation Continue home PO Lasix upon discharge   Normocytic anemia Hg 9.0, was 11.3 on 1/2021 No sign of overt bleeding   HTN On lisinopril, labetalol, diltiazem  Continued outpatient monitoring   Rheumatoid arthritis Resume Leflunomide   Chronic pain On Oxycodone, fentanyl patch(placed on 1/25), tizanidine.  Follows with Pain management
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Cough, Diastolic dysfunction, Dyspnoea
Clinical narrative: Patient is a 68 y.o. female patient of MD with history of  of Anxiety, CHF, Atrial tachycardia, COPD with chronic respiratory failure, seizures OSA presented to the local Hospital with SOB, +COVID infection   Acute on Chronic hypoxic respiratory failure COVID19 infection -patient vaccinated but did not receive booster COPD/OSA + symptoms started more than one week ago with non productive cough and increase SOB CXR stable with chronic mild hazy density throughout both lungs On 2 lit NC 02 and trilogy at home at baseline Required up to 3 L but now down to her baseline of 2 L O2 requirement  elevated CRP, improvement noted with Decadron. Decadron, Mucinex, IS/PEP upon discharge Continued breathing treatment and homeTrilogy   HFpEF, chronic ECHO in 2020 EF 65 %. grade I diastolic dysfunction, consistent with low or normal atrial pressures. RVSP 25 mmHg. Low suspicion for exacerbation Continue home PO Lasix upon discharge   Normocytic anemia Hg 9.0, was 11.3 on 1/2021 No sign of overt bleeding   HTN On lisinopril, labetalol, diltiazem  Continued outpatient monitoring   Rheumatoid arthritis Resume Leflunomide   Chronic pain On Oxycodone, fentanyl patch(placed on 1/25), tizanidine.  Follows with Pain management
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Lung disorder, Normocytic anaemia, Obstructive sleep apnoea syndrome, Respiratory failure
Clinical narrative: Patient is a 68 y.o. female patient of MD with history of  of Anxiety, CHF, Atrial tachycardia, COPD with chronic respiratory failure, seizures OSA presented to the local Hospital with SOB, +COVID infection   Acute on Chronic hypoxic respiratory failure COVID19 infection -patient vaccinated but did not receive booster COPD/OSA + symptoms started more than one week ago with non productive cough and increase SOB CXR stable with chronic mild hazy density throughout both lungs On 2 lit NC 02 and trilogy at home at baseline Required up to 3 L but now down to her baseline of 2 L O2 requirement  elevated CRP, improvement noted with Decadron. Decadron, Mucinex, IS/PEP upon discharge Continued breathing treatment and homeTrilogy   HFpEF, chronic ECHO in 2020 EF 65 %. grade I diastolic dysfunction, consistent with low or normal atrial pressures. RVSP 25 mmHg. Low suspicion for exacerbation Continue home PO Lasix upon discharge   Normocytic anemia Hg 9.0, was 11.3 on 1/2021 No sign of overt bleeding   HTN On lisinopril, labetalol, diltiazem  Continued outpatient monitoring   Rheumatoid arthritis Resume Leflunomide   Chronic pain On Oxycodone, fentanyl patch(placed on 1/25), tizanidine.  Follows with Pain management
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient is a 68 y.o. female patient of MD with history of  of Anxiety, CHF, Atrial tachycardia, COPD with chronic respiratory failure, seizures OSA presented to the local Hospital with SOB, +COVID infection   Acute on Chronic hypoxic respiratory failure COVID19 infection -patient vaccinated but did not receive booster COPD/OSA + symptoms started more than one week ago with non productive cough and increase SOB CXR stable with chronic mild hazy density throughout both lungs On 2 lit NC 02 and trilogy at home at baseline Required up to 3 L but now down to her baseline of 2 L O2 requirement  elevated CRP, improvement noted with Decadron. Decadron, Mucinex, IS/PEP upon discharge Continued breathing treatment and homeTrilogy   HFpEF, chronic ECHO in 2020 EF 65 %. grade I diastolic dysfunction, consistent with low or normal atrial pressures. RVSP 25 mmHg. Low suspicion for exacerbation Continue home PO Lasix upon discharge   Normocytic anemia Hg 9.0, was 11.3 on 1/2021 No sign of overt bleeding   HTN On lisinopril, labetalol, diltiazem  Continued outpatient monitoring   Rheumatoid arthritis Resume Leflunomide   Chronic pain On Oxycodone, fentanyl patch(placed on 1/25), tizanidine.  Follows with Pain management
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, C-reactive protein increased, COVID-19, Chest X-ray normal, Cough
Clinical narrative: Patient is a 56 y.o. female patient of DO with history of Anxiety, right eye blind, CAD, endometrial cancer, DM2, hyperlipidemia, hypertension, and stroke presented to Grady Memorial Hospital with 4 days of myalgia, headache, sinus congestion, cough, diarrhea, and emesis and found to have COVID-19 and Influenza.    Influenza A Status post influenza vaccine in 2022 Chest x-ray without infiltrates Tamiflu started on admission and continued at discharge to complete 5 days course   Covid-19 Virus Infection Acute hypoxic respiratory failure  Date of onset of symptoms: 10/26/22 Symptoms present on admission: headache, myalgia, cough, diarrhea Date of covid positive test: 10/29/22 Vaccination status: vaccinated and 1st booster Imaging: CXR without infiltrates O2 requirement: Required up to 4 L of oxygen but was able to wean down to RA prior to discharge Medical therapy: Dexamethasone started 10/29/22 and IV remdesivir 10/30/22. CRP 186.  DC home on dexamethasone to complete 10 days course Anticipated special isolation end date: 11/6/22 Nighttime pulse oximetry study without desaturations Checked O2 requirement at discharge.Did not qualify for O2   Right flank pain, resolved Isolated episode resolved without any intervention Reports pain in the right flank area radiating to groin area overnight now resolved History of kidney stone in her 20s UA unremarkable.     DM2  A1c of 12 in October 2022 Held home semaglutide and metformin in the hospital but resumed at discharge Increased home Lantus from 25 units to 40 units due to hyperglycemia in the hospital along with SSI At discharge, since we are resuming home semaglutide and metformin, advised patient to continue home dose of Lantus, but to check blood sugar TID AC & HS and if blood sugar runs high to increase the dose of Lantus-30 to 35 units while patient on steroids.  Verbalized understanding  History of stroke Residual right-sided neuropathy and vision loss Continue home Aggrenox and statin   Hypertension Home Rx: Lisinopril/HCTZ 20/12.5 mg daily, Lopressor 100 mg BID, Norvasc 10 mg daily-continue BP stable
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Diarrhoea, Flank pain, Glycosylated haemoglobin, Groin pain, Headache
Clinical narrative: Patient is a 56 y.o. female patient of DO with history of Anxiety, right eye blind, CAD, endometrial cancer, DM2, hyperlipidemia, hypertension, and stroke presented to Grady Memorial Hospital with 4 days of myalgia, headache, sinus congestion, cough, diarrhea, and emesis and found to have COVID-19 and Influenza.    Influenza A Status post influenza vaccine in 2022 Chest x-ray without infiltrates Tamiflu started on admission and continued at discharge to complete 5 days course   Covid-19 Virus Infection Acute hypoxic respiratory failure  Date of onset of symptoms: 10/26/22 Symptoms present on admission: headache, myalgia, cough, diarrhea Date of covid positive test: 10/29/22 Vaccination status: vaccinated and 1st booster Imaging: CXR without infiltrates O2 requirement: Required up to 4 L of oxygen but was able to wean down to RA prior to discharge Medical therapy: Dexamethasone started 10/29/22 and IV remdesivir 10/30/22. CRP 186.  DC home on dexamethasone to complete 10 days course Anticipated special isolation end date: 11/6/22 Nighttime pulse oximetry study without desaturations Checked O2 requirement at discharge.Did not qualify for O2   Right flank pain, resolved Isolated episode resolved without any intervention Reports pain in the right flank area radiating to groin area overnight now resolved History of kidney stone in her 20s UA unremarkable.     DM2  A1c of 12 in October 2022 Held home semaglutide and metformin in the hospital but resumed at discharge Increased home Lantus from 25 units to 40 units due to hyperglycemia in the hospital along with SSI At discharge, since we are resuming home semaglutide and metformin, advised patient to continue home dose of Lantus, but to check blood sugar TID AC & HS and if blood sugar runs high to increase the dose of Lantus-30 to 35 units while patient on steroids.  Verbalized understanding  History of stroke Residual right-sided neuropathy and vision loss Continue home Aggrenox and statin   Hypertension Home Rx: Lisinopril/HCTZ 20/12.5 mg daily, Lopressor 100 mg BID, Norvasc 10 mg daily-continue BP stable
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hyperglycaemia, Influenza, Influenza A virus test positive, Myalgia, Pain
Clinical narrative: Patient is a 56 y.o. female patient of DO with history of Anxiety, right eye blind, CAD, endometrial cancer, DM2, hyperlipidemia, hypertension, and stroke presented to Grady Memorial Hospital with 4 days of myalgia, headache, sinus congestion, cough, diarrhea, and emesis and found to have COVID-19 and Influenza.    Influenza A Status post influenza vaccine in 2022 Chest x-ray without infiltrates Tamiflu started on admission and continued at discharge to complete 5 days course   Covid-19 Virus Infection Acute hypoxic respiratory failure  Date of onset of symptoms: 10/26/22 Symptoms present on admission: headache, myalgia, cough, diarrhea Date of covid positive test: 10/29/22 Vaccination status: vaccinated and 1st booster Imaging: CXR without infiltrates O2 requirement: Required up to 4 L of oxygen but was able to wean down to RA prior to discharge Medical therapy: Dexamethasone started 10/29/22 and IV remdesivir 10/30/22. CRP 186.  DC home on dexamethasone to complete 10 days course Anticipated special isolation end date: 11/6/22 Nighttime pulse oximetry study without desaturations Checked O2 requirement at discharge.Did not qualify for O2   Right flank pain, resolved Isolated episode resolved without any intervention Reports pain in the right flank area radiating to groin area overnight now resolved History of kidney stone in her 20s UA unremarkable.     DM2  A1c of 12 in October 2022 Held home semaglutide and metformin in the hospital but resumed at discharge Increased home Lantus from 25 units to 40 units due to hyperglycemia in the hospital along with SSI At discharge, since we are resuming home semaglutide and metformin, advised patient to continue home dose of Lantus, but to check blood sugar TID AC & HS and if blood sugar runs high to increase the dose of Lantus-30 to 35 units while patient on steroids.  Verbalized understanding  History of stroke Residual right-sided neuropathy and vision loss Continue home Aggrenox and statin   Hypertension Home Rx: Lisinopril/HCTZ 20/12.5 mg daily, Lopressor 100 mg BID, Norvasc 10 mg daily-continue BP stable
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Sinus congestion, Urine analysis normal, Vomiting
Clinical narrative: Patient is a 56 y.o. female patient of DO with history of Anxiety, right eye blind, CAD, endometrial cancer, DM2, hyperlipidemia, hypertension, and stroke presented to Grady Memorial Hospital with 4 days of myalgia, headache, sinus congestion, cough, diarrhea, and emesis and found to have COVID-19 and Influenza.    Influenza A Status post influenza vaccine in 2022 Chest x-ray without infiltrates Tamiflu started on admission and continued at discharge to complete 5 days course   Covid-19 Virus Infection Acute hypoxic respiratory failure  Date of onset of symptoms: 10/26/22 Symptoms present on admission: headache, myalgia, cough, diarrhea Date of covid positive test: 10/29/22 Vaccination status: vaccinated and 1st booster Imaging: CXR without infiltrates O2 requirement: Required up to 4 L of oxygen but was able to wean down to RA prior to discharge Medical therapy: Dexamethasone started 10/29/22 and IV remdesivir 10/30/22. CRP 186.  DC home on dexamethasone to complete 10 days course Anticipated special isolation end date: 11/6/22 Nighttime pulse oximetry study without desaturations Checked O2 requirement at discharge.Did not qualify for O2   Right flank pain, resolved Isolated episode resolved without any intervention Reports pain in the right flank area radiating to groin area overnight now resolved History of kidney stone in her 20s UA unremarkable.     DM2  A1c of 12 in October 2022 Held home semaglutide and metformin in the hospital but resumed at discharge Increased home Lantus from 25 units to 40 units due to hyperglycemia in the hospital along with SSI At discharge, since we are resuming home semaglutide and metformin, advised patient to continue home dose of Lantus, but to check blood sugar TID AC & HS and if blood sugar runs high to increase the dose of Lantus-30 to 35 units while patient on steroids.  Verbalized understanding  History of stroke Residual right-sided neuropathy and vision loss Continue home Aggrenox and statin   Hypertension Home Rx: Lisinopril/HCTZ 20/12.5 mg daily, Lopressor 100 mg BID, Norvasc 10 mg daily-continue BP stable
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Bowel movement irregularity, Feeling abnormal, Nasopharyngitis
Clinical narrative: Bowel runs, weak and bad feeling, cold
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Menstruation irregular
Clinical narrative: Second menstrual period within thirty days
Age: 95.0
Sex: F
Vaccine: COVID19-2
Symptoms: Death
Clinical narrative: Resident died 11/18/2022 at 7:30 pm.
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Mobility decreased, Pyrexia, Vaginal prolapse
Clinical narrative: I noticed a significant vaginal prolapse while showering, 11/12/22, the day after of receiving a Pfizer bivalent vaccine 11/11/22. There was no prolapse 11/10/22 and I did not notice one 11/11/22. I did nothing different in between the time of the vaccine and the following evening. I spent most of my day laying on the cough with a low grade fever. The prolapse has subsided by the time I went to my visit my PCP on 11/17/22 so no labs were done.
Age: 64.0
Sex: F
Vaccine: PNC20
Symptoms: Arthralgia, Myalgia, Neck pain, Vision blurred, Visual field defect
Clinical narrative: 11/16/22 Rec'd Prevnar 20 vaccine in PCP office, 6 hrs later experience intense muscle/joint/neck pain. The next morning I had wavy lines in my peripheral vision and blurred vision. This lasted about 14 hours and then dissipated. 11/18/22 I have no more issues. 11/17/22 I reported symptoms to PCP
Sex: F
Vaccine: HPV9
Symptoms: Anorectal disorder, Colitis, Colitis ulcerative, Condition aggravated, Emotional distress
Clinical narrative: Approximately 6 months after taking her last HPV vaccine dose, my daughter began seeing blood in her stools accompanied by bouts of exhaustion. She was diagnosed with Ulcerative Colitis and her health has deteriorated since then. Even after trying numerous medications, GI doctors have not been able to bring her into remission since March 2020. She had an ileostomy in Aug of 2020 which ended up worsening her colitis and causing worsening symptoms. She also got perianal disease at this time, which was treated with multiple procedures and a skin flap surgery July 2021, but none of them worked. The surgery left her with wounds around and inside her anus that still have not healed to this day. The anal pain is so intense during the 8-12 stools she has per day that she requires narcotics to get her through them. The past few years have been consumed with pain, sickness, extended hospital stays, and emotional trauma caused by the relentless and unresolved nature of her illness. She missed her entire senior year of high school last year, attempted to return this fall only to repeatedly become sick causing her to take another medical leave. We are not anti-vaxxers. As there is no family history of IBD, we are still baffled by what could have triggered this reaction a once healthy girl. Because the HPV vaccine was the only thing new in her life, we want to be able to warn others in the event it may have had anything to do with this tragic outcome. my daughter has had numerous testing since her diagnosis in 2019. I cannot list them all here but can provide release of her medical records if it would help.
Sex: F
Vaccine: HPV9
Symptoms: Fatigue, Frequent bowel movements, General physical health deterioration, Haematochezia, Ileostomy
Clinical narrative: Approximately 6 months after taking her last HPV vaccine dose, my daughter began seeing blood in her stools accompanied by bouts of exhaustion. She was diagnosed with Ulcerative Colitis and her health has deteriorated since then. Even after trying numerous medications, GI doctors have not been able to bring her into remission since March 2020. She had an ileostomy in Aug of 2020 which ended up worsening her colitis and causing worsening symptoms. She also got perianal disease at this time, which was treated with multiple procedures and a skin flap surgery July 2021, but none of them worked. The surgery left her with wounds around and inside her anus that still have not healed to this day. The anal pain is so intense during the 8-12 stools she has per day that she requires narcotics to get her through them. The past few years have been consumed with pain, sickness, extended hospital stays, and emotional trauma caused by the relentless and unresolved nature of her illness. She missed her entire senior year of high school last year, attempted to return this fall only to repeatedly become sick causing her to take another medical leave. We are not anti-vaxxers. As there is no family history of IBD, we are still baffled by what could have triggered this reaction a once healthy girl. Because the HPV vaccine was the only thing new in her life, we want to be able to warn others in the event it may have had anything to do with this tragic outcome. my daughter has had numerous testing since her diagnosis in 2019. I cannot list them all here but can provide release of her medical records if it would help.
Sex: F
Vaccine: HPV9
Symptoms: Illness, Impaired healing, Injury, Laboratory test, Loss of personal independence in daily activities
Clinical narrative: Approximately 6 months after taking her last HPV vaccine dose, my daughter began seeing blood in her stools accompanied by bouts of exhaustion. She was diagnosed with Ulcerative Colitis and her health has deteriorated since then. Even after trying numerous medications, GI doctors have not been able to bring her into remission since March 2020. She had an ileostomy in Aug of 2020 which ended up worsening her colitis and causing worsening symptoms. She also got perianal disease at this time, which was treated with multiple procedures and a skin flap surgery July 2021, but none of them worked. The surgery left her with wounds around and inside her anus that still have not healed to this day. The anal pain is so intense during the 8-12 stools she has per day that she requires narcotics to get her through them. The past few years have been consumed with pain, sickness, extended hospital stays, and emotional trauma caused by the relentless and unresolved nature of her illness. She missed her entire senior year of high school last year, attempted to return this fall only to repeatedly become sick causing her to take another medical leave. We are not anti-vaxxers. As there is no family history of IBD, we are still baffled by what could have triggered this reaction a once healthy girl. Because the HPV vaccine was the only thing new in her life, we want to be able to warn others in the event it may have had anything to do with this tragic outcome. my daughter has had numerous testing since her diagnosis in 2019. I cannot list them all here but can provide release of her medical records if it would help.
Sex: F
Vaccine: HPV9
Symptoms: Plastic surgery, Procedural failure, Proctalgia, Surgical failure, Therapeutic procedure
Clinical narrative: Approximately 6 months after taking her last HPV vaccine dose, my daughter began seeing blood in her stools accompanied by bouts of exhaustion. She was diagnosed with Ulcerative Colitis and her health has deteriorated since then. Even after trying numerous medications, GI doctors have not been able to bring her into remission since March 2020. She had an ileostomy in Aug of 2020 which ended up worsening her colitis and causing worsening symptoms. She also got perianal disease at this time, which was treated with multiple procedures and a skin flap surgery July 2021, but none of them worked. The surgery left her with wounds around and inside her anus that still have not healed to this day. The anal pain is so intense during the 8-12 stools she has per day that she requires narcotics to get her through them. The past few years have been consumed with pain, sickness, extended hospital stays, and emotional trauma caused by the relentless and unresolved nature of her illness. She missed her entire senior year of high school last year, attempted to return this fall only to repeatedly become sick causing her to take another medical leave. We are not anti-vaxxers. As there is no family history of IBD, we are still baffled by what could have triggered this reaction a once healthy girl. Because the HPV vaccine was the only thing new in her life, we want to be able to warn others in the event it may have had anything to do with this tragic outcome. my daughter has had numerous testing since her diagnosis in 2019. I cannot list them all here but can provide release of her medical records if it would help.